Lilium Welcomes Aerospace Industry Veteran Philippe Balducchi to Board of Directors
September 12, 2024 07:30 ET
|
Lilium GmbH
Philippe Balducchi is CFO of KNDS, one of Europe’s largest defense companiesPreviously: CEO of Airbus Canada, Head of Bombardier C-Series/A220 integration, CFO of Airbus North AmericaAppointment due...
Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit
September 12, 2024 07:30 ET
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
Amesite Launches NurseMagic™ Pilot Programs with Five Healthcare Companies
September 12, 2024 07:30 ET
|
Amesite Inc.
DETROIT, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced...
Kelly Announces Chief Financial Officer Transition
September 12, 2024 07:30 ET
|
Kelly Services, Inc.
TROY, Mich., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced that Troy R. Anderson has been named executive...
Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting
September 12, 2024 07:30 ET
|
Intellia Therapeutics, Inc.
First presentation of detailed Phase 2 results following previous positive topline announcement that study of NTLA-2002 met primary and all secondary endpoints Intellia to host investor webcast on...
Biogen Board Appoints Two New Independent Directors
September 12, 2024 07:30 ET
|
Biogen Inc.
CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The Biogen Inc. (Nasdaq: BIIB) Board of Directors (the “Board”) today announced the appointments of two new independent directors, Lloyd B....
Oruka Therapeutics Announces $200 Million Private Placement
September 12, 2024 07:05 ET
|
Oruka Therapeutics, Inc.
MENLO PARK, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka” or the “Company”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new...
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
September 12, 2024 07:05 ET
|
OrthoPediatrics Corp.
WARSAW, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced...
Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA™ (pemivibart) to Help Protect Vulnerable Immunocompromised Persons from COVID-19
September 12, 2024 07:01 ET
|
Invivyd
Centers for Disease Control and Prevention (CDC) reports death rate due to COVID-19 has continued to increase throughout 2024 Immunocompromised patients at greatest risk for serious infections or even...
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
September 12, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...